Rat surfactant protein D (SP-D) was shown to enhance the production of oxygen radicals by rat alveolar macrophages. This enhancement, which was determined by a lucigenin-dependent chemiluminescence assay, was maximal after 18 min at an SP-D concentration of 0.2 ,tg/ml. Surfactant lipids did not influence the stimulation of alveolar macrophages by SP-D, whereas the oxygen-radical production of these cells induced by surfactant protein A was inhibited by the lipids in a concentration-dependent manner.
INTRODUCTION
Pulmonary surfactant is a complex of lipids, proteins and carbohydrates that lines the alveolar surfaces of the lung. Its major function is to prevent alveolar collapse at end-expiration.
One of the most abundant surfactant proteins is surfactant protein A (SP-A), which is synthesized and secreted by alveolar type II cells [1, 2] . SP-A has been shown to enhance the adsorption of phospholipids to the monolayer at the air/liquid interface in the presence of surfactant protein B [3] and to regulate the homoeostasis of extracellular surfactant [4] [5] [6] . In addition, SP-A may also be involved in the host-defence system of the lung, as it has been shown to act as an opsonin for viruses [7] and to stimulate alveolar macrophages [7] [8] [9] .
In 1988 another hydrophilic surfactant-associated protein was described by Persson et al. [10] , namely surfactant protein D (SP-D). SP-D is a collagen-domain-containmng glycoprotein that is synthesized and secreted by rat type II cells [10,11} . SP-D isolated from broncho-alveolar lavage is a multimeric complex of disulphide-bonded trimers comprised of apparently identical subunits, each with a molecular mass of 130 kDa [10, 12] . SP-D is also a Ca2+-dependent carbohydrate-binding protein and is structurally related to other C-type mammalian lectins, such as conglutinin and SP-A [13,141. The complete cDNA coding sequence and deduced amino acid sequence of rat SP-D have recently been reported by Shimizu et al. [15] . The structural similarities of SP-D and SP-A raise the possibility that these proteins have related functions.
In the present study we demonstrate, using a lucigenindependent chemiluminescence assay, that SP-D can stimulate alveolar macrophages to generate oxygen radicals.
MATERIALS AND METHODS
Purification of SP-D Rats were given an intratracheal instillation of silica to induce alveolar lipoproteinosis [16] , and SP-D was prepared from lung lavage essentially as described by Persson et al. [12, 17] . BaSO4 powder was added to the surfactant-depleted lavage supernatant (80 mg/ml) and the solution was stirred at room temperature for 30 min. The adsorbant was collected by centrifugation at 10000 g and washed twice with 150 mM-NaCI/50 mM-Tris/HCI, pH 7.5 (TBS), containing 2.5 mM-sodium citrate. SP-D was eluted from the adsorbant by washing with TBS containing 200 mM-sodium citrate. The preparation was dialysed against TBS containing 2 mM-CaC12 and applied to a mannose-Sepharose 6B column [18] equilibrated with the same buffer. Proteins bound to the column were eluted with TBS containing 10 mM-EDTA. The eluted material was applied to a column of Sephacryl S-500 (Pharmacia LKB Biotechnology) and SP-D was eluted with an apparent molecular mass of 2.3 MDa.
Antisera
To generate an antiserum, 100 ,ug of purified SP-D was prepared in complete Freund's adjuvant and injected intramuscularly into rabbits. The initial immunization was followed by a second administration of SP-D antigen (70 ,isg) in incomplete adjuvant and a third administration (70 ,sg) without adjuvant. The IgG fraction was purified by affinity chromatography using a Protein A-Sepharose CL4B column (Pharmacia). The IgG fraction was also absorbed by passage over rat-serum-conjugated Affi-Gel 10 and 15 (Bio-Rad) columns [15] . Antibody specificity for SP-D was confirmed by immunoblot analysis [15] . F(ab')2 fragments of the IgG fraction were prepared and purified as described by Parham et al. [19] . The fragments were dissolved in TBS (0.6 mg/ml) and stored at -20 'C.
Isolation of SP-A and surfactant lipids SP-A was isolated from broncho-alveolar lavage fluid of patients with alveolar proteinosis as previously described [20] . SP-A was dissolved in 5 mM-Hepes buffer, pH 7.4 (1 mg/ml), and stored in small aliquots at -70 'C.
Lipids were extracted from rat pulmonary surfactant by the Bligh & Dyer technique [21] , as described previously [8] . The lipids were suspended in TBS to a concentration of 1.1 mg of phospholipids/ml.
Isolation of rat alveolar and peritoneal macrophages
Rat alveolar macrophages were isolated from male specificpathogen-free Wistar rats (200-225 g body wt.) as described previously [8] . The macrophages were suspended in 140 mMNaCl / 5 mM-KCI / 2.5 mM-Na2HPO4 / 10 mM-Hepes / 2 mMMgSO4/6 mM-glucose/2 mM-CaCl2, pH 7.4, supplemented with 0.1 % (w/v) gelatin (buffer A) to a concentration of 2 x 106 cells/ml.
Rat peritoneal macrophages were isolated as described previously [8] . The macrophages were suspended in buffer A to a concentration of 2 x 106 cells/ml. The peritoneal leucocytes used in the present study consisted of more than 80% peritoneal macrophages.
Chemiluminescence assay
The generation of oxygen radicals by rat macrophages was monitored by using the lucigenin-dependent chemiluminescence assay described in [8] . Briefly, the chemiluminescence response of 3.5 x 105 macrophages incubated with various concentrations of SP-D or SP-A or phorbol 12-myristate 13-acetate (PMA) in the presence of lucigenin (250 /M) was determined. The assay volume was 0.4 ml. Chemiluminescence was measured at 37°C in a luminometer for 3 s every 2 min over a 30 min period. Except for the time course where the chemiluminescence response was depicted every 2 min, peak signals of the chemiluminescence responses were used to compare the various experimental conditions.
RESULTS AND DISCUSSION
Enhancement of the production of oxygen radicals by alveolar macrophages induced by SP-D SP-D enhanced the production of oxygen radicals by rat alveolar macrophages (Fig. 1) . The enhancement was timedependent, starting after 6 min and reaching a maximum after (Fig. 2) . Maximal stimulation of the alveolar macrophages was observed at a concentration of 0.2 jug of SP-D/ml, whereas the SP-A-mediated chemiluminescence was initiated at 0. 25 plateau at 1 1ug of SP-A/ml [8] . The concentration of SP-D present in the bronchoalveolar lavage of rats is 10 ug/rat [22] . [23, 24] . F(ab')2 fragments of an IgG fraction directed against SP-D completely abolished the SP-D-induced production of oxygen radicals (Fig. 3) , indicating that alveolar macrophages are truly stimulated by SP-D. The F(ab')2 fragments directed against SP-D did not influence the SP-A-induced activation of alveolar macrophages. In addition, the F(ab')2 fragments alone did not induce oxygen-radical production by the macrophages. No chemiluminescence response was detected when alveolar macrophages were incubated with either SP-A or SP-D in the presence of superoxide dismutase, an enzyme which converts superoxide into H202, indicating that both SP-A and SP-D stimulate the macrophages to produce superoxide radicals (results not shown).
Effect of SP-D on peritoneal macrophages Table 1 shows that peritoneal macrophages, in contrast with alveolar macrophages, cannot be stimulated by SP-D to elicit a chemiluminescence response. Previously we reported that also SP-A can only stimulate alveolar macrophages to generate superoxide [8] . Whether SP-A and SP-D bind to a similar receptor on the alveolar macrophage, which is not present on other phagocytes, or whether the observed similar specificity of SP-D and SP-A for alveolar macrophages is merely coincidental, is not known, but would be an interesting topic for future research.
Influence of surfactant lipids on the activation of alveolar macrophages
We also studied the influence of surfactant lipids on the activation of alveolar macrophages by SP-A and SP-D (Fig. 4) . The lipids had no effect on the SP-D-induced chemiluminescence response by rat alveolar macrophages. However, they completely inhibited the activation of alveolar macrophages by SP The SP-A preparation used in the present study was derived from alveolar-proteinosis patients. As has been reviewed by Hawgood [2] , there are some structural diffe ences between SP-A isolated from alveolar-proteinosis patients and rat SP-A. This could suggest that the effects observed in the present study would be restricted to human SP-A and rat alveolar macrophages. Table 1 ). In conjunction with the published studies on the functional similarity of-human and-rat SP-A mentioned above, it seems very likely that the results obtained in the present study with human SP-A can be extrapolated to rat SP-A. SP-A is known to bind to phospholipids and to form lipid aggregates in the presence of Ca2+ [28] [29] [30] . Therefore a possible explanation for the observed inhibitory effect of lipids on SP-Ainduced stimulation of the macrophages could be that SP-A binds to lipids and forms vesicles that prevent interaction of SP-A with the macrophages. An alternative explanation that cannot be fully excluded is that lipids compete with alveolar macrophages for the same binding site on the SP-A molecule.
SP-D cannot induce lipid aggregation [22] . In addition, approximately only 25 % of the SP-D present in the bronchoalveolar lavage of rats is found associated with particulate pulmonary surfactant [22] . The weak interaction of SP-D with phospholipids may therefore explain why phospholipids do not inhibit the SP-D-induced stimulation of alveolar macrophages.
To conclude from these results that SP-D may be more important in the alveolar defence than SP-A, because SPA is inhibited by the surfactant lipids, whereas SP-D is not, would be premature. The contribution of SP-A and SP-D secreted by Clara cells [23, 24] to the concentrations of these proteins in the alveoli, and the stimulation of the secretion of SP-A by yinterferon [31] , which does not result in increased surfactant lipid concentrations, are, for example, factors that may influence the balance between SP-A, SP-D and phospholipids in the alveoli. In conclusion, our findings demonstrate that SP-D can activate Vol. 286 alveolar macrophages to produce superoxide radicals, and may therefore play a role in the host-defence system of the lung. 
